The visit showcased how Slade Health is helping strengthen care for New Zealand patients through high-quality sterile compounding, digital innovation and strong public private partnership.
As one of New Zealand’s leading Medsafe-licensed sterile compounding providers, Slade Health prepares more than 400 infusions each day from its Auckland facility for hospitals across the country. This includes chemotherapy, antibiotics, analgesics and clinical trial medicines.
